NP-06 - A NOVEL ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS POLYPEPTIDE PRODUCED BY A STREPTOMYCES SPECIES

被引：34

作者：

CHOKEKIJCHAI, S

KOJIMA, E

ANDERSON, S

NOMIZU, M

TANAKA, M

MACHIDA, M

DATE, T

TOYOTA, K

ISHIDA, S

WATANABE, K

YOSHIOKA, H

ROLLER, PP

MURAKAMI, K

MITSUYA, H

机构：

[1] NCI,DIV CANC TREATMENT,MED BRANCH,EXPTL RETROVIRUS SECT,BETHESDA,MD 20892

[2] NCI,DIV CANC TREATMENT,MED CHEM LAB,BETHESDA,MD 20892

[3] NHLBI,HEMATOL BRANCH,BETHESDA,MD 20892

[4] NIDR,DEV BIOL LAB,BETHESDA,MD 20892

[5] NIPPON PAPER IND CO LTD,BIOSCI RES LAB,IWAKUNI,JAPAN

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1995年 / 39卷 / 10期

关键词：

D O I：

10.1128/AAC.39.10.2345

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

From an extract of a Streptomyces culture, we identified and purified a novel compound, NP-06, which is active against human immunodeficiency virus (HIV) in vitro. Analyses indicate that NP-06 is a hydrophobic 21-mer oligopeptide, N terminally cyclized through the side chain of Asp-9, containing two intramolecular cystine linkages with a molecular weight of 2,163.4. The 50% inhibitory concentrations were 2.8 and 1.3 mu M when NP-06 was tested for in vitro anti-HIV-1 activity in ATH8 cells and phytohemagglutinin activated peripheral blood mononuclear cells, respectively. NP-06 appears to block the early stage of HIV-1 infection, most likely at the stage of virus-cell fusion.

引用

收藏

页码：2345 / 2347

页数：3

相关论文

共 12 条

[1] PRECLINICAL EVALUATION OF MKC-442, A HIGHLY POTENT AND SPECIFIC INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN-VITRO [J].

BABA, M ;

SHIGETA, S ;

YUASA, S ;

TAKASHIMA, H ;

SEKIYA, K ;

UBASAWA, M ;

TANAKA, H ;

MIYASAKA, T ;

WALKER, RT ;

DECLERCQ, E .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (04) :688-692

[2] STRUCTURE OF HIV-1 PROTEASE WITH KNI-272, A TIGHT-BINDING TRANSITION-STATE ANALOG CONTAINING ALLOPHENYLNORSTATINE [J].

BALDWIN, ET ;

BHAT, TN ;

GULNIK, S ;

LIU, BS ;

TOPOL, IA ;

KISO, Y ;

MIMOTO, T ;

MITSUYA, H ;

ERICKSON, JW .

STRUCTURE, 1995, 3 (06) :581-590

[3] INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS INTEGRASE [J].

FESEN, MR ;

KOHN, KW ;

LETEURTRE, F ;

POMMIER, Y .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (06) :2399-2403

[4] SOLUTION STRUCTURE OF RP-71955, A NEW 21 AMINO-ACID TRICYCLIC PEPTIDE ACTIVE AGAINST HIV-1 VIRUS [J].

FRECHET, D ;

GUITTON, JD ;

HERMAN, F ;

FAUCHER, D ;

HELYNCK, G ;

DUSORBIER, BM ;

RIDOUX, JP ;

JAMESSURCOUF, E ;

VUILHORGNE, M .

BIOCHEMISTRY, 1994, 33 (01) :42-50

[5] A NOVEL ANTI-HIV SYNTHETIC PEPTIDE, T-22 ([TYR5,12,LYS7]-POLYPHEMUSIN-II) [J].

MASUDA, M ;

NAKASHIMA, H ;

UEDA, T ;

NABA, H ;

IKOMA, R ;

OTAKA, A ;

TERAKAWA, Y ;

TAMAMURA, H ;

IBUKA, T ;

MURAKAMI, T ;

KOYANAGI, Y ;

WAKI, M ;

MATSUMOTO, A ;

YAMAMOTO, N ;

FUNAKOSHI, S ;

FUJII, N .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 189 (02) :845-850

[6] CHARACTERIZATION OF A HUMAN IMMUNODEFICIENCY VIRUS NEUTRALIZING MONOCLONAL-ANTIBODY AND MAPPING OF THE NEUTRALIZING EPITOPE [J].

MATSUSHITA, S ;

ROBERTGUROFF, M ;

RUSCHE, J ;

KOITO, A ;

HATTORI, T ;

HOSHINO, H ;

JAVAHERIAN, K ;

TAKATSUKI, K ;

PUTNEY, S .

JOURNAL OF VIROLOGY, 1988, 62 (06) :2107-2114

[7] 3'-AZIDO-3'-DEOXYTHYMIDINE (BW A509U) - AN ANTIVIRAL AGENT THAT INHIBITS THE INFECTIVITY AND CYTOPATHIC EFFECT OF HUMAN LYMPHOTROPIC-T VIRUS TYPE-III LYMPHADENOPATHY-ASSOCIATED VIRUS INVITRO [J].

MITSUYA, H ;

WEINHOLD, KJ ;

FURMAN, PA ;

STCLAIR, MH ;

LEHRMAN, SN ;

GALLO, RC ;

BOLOGNESI, D ;

BARRY, DW ;

BRODER, S .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (20) :7096-7100

[8] ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ACTIVITY OF A NOVEL SYNTHETIC PEPTIDE, T22 ([TYR-5,12, LYS-7]POLYPHEMUSIN II) - A POSSIBLE INHIBITOR OF VIRUS-CELL FUSION [J].

NAKASHIMA, H ;

MASUDA, M ;

MURAKAMI, T ;

KOYANAGI, Y ;

MATSUMOTO, A ;

FUJII, N ;

YAMAMOTO, N .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (06) :1249-1255

[9] RAPID AND AUTOMATED TETRAZOLIUM-BASED COLORIMETRIC ASSAY FOR THE DETECTION OF ANTI-HIV COMPOUNDS [J].

PAUWELS, R ;

BALZARINI, J ;

BABA, M ;

SNOECK, R ;

SCHOLS, D ;

HERDEWIJN, P ;

DESMYTER, J ;

DECLERCQ, E .

JOURNAL OF VIROLOGICAL METHODS, 1988, 20 (04) :309-321

[10]

RICHMAN DD, 1993, CURRENT PROTOCOLS IM